Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

Fig. 2

PD-1 disruption promotes favorable differentiation of CAR T cells targeting PD-L1 expressing glioma. Effector cells were cocultured with irradiated target U87vIII at and E:T of 1:1. The phenotype of T cells were assessed at Day 1 (prior to stimulation) and at Day 21 by flow cytometry. Cells were grouped by flow cytometry according to T-cell phenotype as follows: naïve (TN) CCR7+CD45RO, central memory (TCM) CCR7+CD45RO+, effector memory (TEM) CCR7CD45RO+, and effector (TE) CCR7CD45RO

Back to article page